Skip to main content
. 2021 Jun 15;13(6):6439–6445.

Table 1.

Baseline data of the two groups [n (%), mean ± SEM]

Factor n The research group (n=124) Control group (n=99) χ2/t P-value
Age (Y) 0.541 0.462
    <50 121 70 (56.45) 51 (51.52)
    ≥50 102 54 (43.55) 48 (48.48)
Mean age (Y) 223 46.84±17.37 48.49±16.96 0.712 0.477
HPV infection 2.899 0.089
    No 22 16 (12.90) 6 (6.06)
    Yes 201 108 (87.10) 93 (93.94)
Lymph node metastasis 0.678 0.410
    No 108 57 (45.97) 51 (51.52)
    Yes 115 67 (54.03) 48 (48.48)
TNM stage 3.760 0.053
    I-II 101 49 (39.52) 52 (52.53)
    III-IV 122 75 (60.48) 47 (47.47)
Pathological grade 0.212 0.646
    G1 78 45 (36.29) 33 (33.33)
    G2-G3 145 79 (63.71) 66 (66.67)
Tumor size (cm) 0.163 0.686
    <4 107 58 (46.77) 49 (49.49)
    ≥4 116 66 (53.23) 50 (50.51)
Smoking history 2.045 0.153
    No 153 90 (72.58) 63 (63.64)
    Yes 70 34 (27.42) 36 (36.36)
Abortion history 0.736 0.391
    No 164 94 (75.81) 70 (70.71)
    Yes 59 30 (24.19) 29 (29.29)
Place of residence 0.201 0.654
    Rural area 87 50 (40.32) 37 (37.37)
    Urban area 136 74 (59.68) 62 (62.63)